Protein Engineering Market By Product (Instruments, Consumables, Software), By Technology Type (Rational or Site Directed Mutagenesis, Irrational or Random Mutagenesis), By Protein Type (Monoclonal Antibodies, Insulin, Erythropoietin, Interferon, Others), By End User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Contract Research Organizations): Global Opportunity Analysis and Industry Forecast, 2023-2032
The global protein engineering market was valued at $2,227.15 million in 2022 and is projected to reach $7,709.32 million by 2032, registering a CAGR of 13.2% from 2023 to 2032.
Protein engineering is the process by which a scientist alters the sequence of a protein by adding, deleting, or substituting nucleotides in the encoding gene to produce a modified protein that is better suited than the original protein for a given use or objective. There are two general strategies for protein engineering such as rational protein design and directed evolution. In rational protein design, a scientist modifies a protein by using in-depth understanding of its structure and function. Since site-directed mutagenesis techniques are well-established, this generally has the benefit of being affordable and simple to implement technically.
In addition, in directed evolution, a protein is subjected to random mutagenesis, such as sequence saturation mutagenesis or error-prone PCR mutagenesis, and variants with desirable features are chosen by a selection regime. Then, more iterations of selection and mutation are used. In general, this approach outperforms rational design since it emulates natural evolution.
The major factors driving the growth of protein engineering market are the growing demand for biopharmaceuticals, including monoclonal antibodies, vaccines, and therapeutic proteins. Protein engineering plays a crucial role in optimizing the properties of these biologics, improving their efficacy, safety, and specificity, which drive growth of the protein engineering market. In addition, rising investments from both public and private sectors in R&D activities related to protein engineering contribute to the market growth.
Furthermore, continuous advancements in protein engineering technologies, such as CRISPR-based approaches, directed evolution, and computational protein design, are driving the market growth. These technologies enable more precise and efficient manipulation of protein structures and functions.
Protein engineering accelerates drug development by providing tools to design and modify proteins for therapeutic purposes. In addition, rise in prevalence of chronic diseases, such as cancer, autoimmune disorders, and metabolic diseases, fuels the demand for innovative therapeutic solutions as engineered proteins offer targeted and personalized treatment options.
The protein engineering market is segmented into product, protein type, technology type, end user, and region. By product, the market is segregated into instruments, consumables, and software. By protein type, the market is classified into monoclonal antibodies, insulin, erythropoietin, interferon, and others. The others segment further includes interleukin, transforming growth factors, epidermal growth factors, tumor necrosis factor, stem cell factor, colony stimulating factors, growth factors, and coagulation factors. By technology type, the market is segregated into rational/ site directed mutagenesis, and irrational/ random mutagenesis.
By end user, the market is divided into pharmaceutical & biotechnological companies, academic & research institutes, and contract research organizations. Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (India, China, Japan, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Major key players that operate in the global protein engineering market are Agilent Technologies, Inc., Thermo Fisher Scientific Inc., Takara Holdings, Inc., Promega Corporation, New England Biolabs, Jena Bioscience GmbH, Danaher Corporation, Creative Biolabs, Amgen, Inc., and Bio-Rad laboratories, Inc. The key players have adopted strategies such as product launch, partnership, and acquisition to expand their product portfolio
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the protein engineering market analysis from 2022 to 2032 to identify the prevailing protein engineering market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the protein engineering market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global protein engineering market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By End User
Pharmaceutical and Biotechnology Companies
Academic Research Institutes
Contract Research Organizations
By Product
Instruments
Consumables
Software
By Technology Type
Rational or Site Directed Mutagenesis
Irrational or Random Mutagenesis
By Protein Type
Monoclonal Antibodies
Insulin
Erythropoietin
Interferon
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Agilent Technologies, Inc.
Promega Corporation
New England Biolabs, Inc.
Danaher Corporation
Bio-Rad Laboratories, Inc.
Amgen, Inc.
TAKARA HOLDINGS INC.
Thermo Fisher Scientific Inc.
Creative Biolabs Limited
Jena Bioscience GmbH
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter’s five forces analysis
- 3.3.1. Moderate bargaining power of suppliers
- 3.3.2. Moderate threat of new entrants
- 3.3.3. Moderate threat of substitutes
- 3.3.4. High intensity of rivalry
- 3.3.5. Moderate bargaining power of buyers
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Increasing research & development activities in the biopharmaceutical industry
- 3.4.1.2. Technological advancements in protein engineering
- 3.4.1.3. Increase in developmental strategies in protein engineering by key players
- 3.4.2. Restraints
- 3.4.2.1. High cost and maintenance of protein engineering systems
- 3.4.3. Opportunities
- 3.4.3.1. Growth in opportunities in emerging markets
- CHAPTER 4: PROTEIN ENGINEERING MARKET, BY PRODUCT
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Instruments
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.3. Consumables
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.4. Software
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
- CHAPTER 5: PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Rational or Site Directed Mutagenesis
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Irrational or Random Mutagenesis
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- CHAPTER 6: PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. Monoclonal Antibodies
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. Insulin
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- 6.4. Erythropoietin
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
- 6.5. Interferon
- 6.5.1. Key market trends, growth factors and opportunities
- 6.5.2. Market size and forecast, by region
- 6.5.3. Market share analysis by country
- 6.6. Others
- 6.6.1. Key market trends, growth factors and opportunities
- 6.6.2. Market size and forecast, by region
- 6.6.3. Market share analysis by country
- CHAPTER 7: PROTEIN ENGINEERING MARKET, BY END USER
- 7.1. Overview
- 7.1.1. Market size and forecast
- 7.2. Pharmaceutical and Biotechnology Companies
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by region
- 7.2.3. Market share analysis by country
- 7.3. Academic Research Institutes
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by region
- 7.3.3. Market share analysis by country
- 7.4. Contract Research Organizations
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by region
- 7.4.3. Market share analysis by country
- CHAPTER 8: PROTEIN ENGINEERING MARKET, BY REGION
- 8.1. Overview
- 8.1.1. Market size and forecast By Region
- 8.2. North America
- 8.2.1. Key market trends, growth factors and opportunities
- 8.2.2. Market size and forecast, by Product
- 8.2.3. Market size and forecast, by Technology Type
- 8.2.4. Market size and forecast, by Protein Type
- 8.2.5. Market size and forecast, by End User
- 8.2.6. Market size and forecast, by country
- 8.2.6.1. U.S.
- 8.2.6.1.1. Market size and forecast, by Product
- 8.2.6.1.2. Market size and forecast, by Technology Type
- 8.2.6.1.3. Market size and forecast, by Protein Type
- 8.2.6.1.4. Market size and forecast, by End User
- 8.2.6.2. Canada
- 8.2.6.2.1. Market size and forecast, by Product
- 8.2.6.2.2. Market size and forecast, by Technology Type
- 8.2.6.2.3. Market size and forecast, by Protein Type
- 8.2.6.2.4. Market size and forecast, by End User
- 8.2.6.3. Mexico
- 8.2.6.3.1. Market size and forecast, by Product
- 8.2.6.3.2. Market size and forecast, by Technology Type
- 8.2.6.3.3. Market size and forecast, by Protein Type
- 8.2.6.3.4. Market size and forecast, by End User
- 8.3. Europe
- 8.3.1. Key market trends, growth factors and opportunities
- 8.3.2. Market size and forecast, by Product
- 8.3.3. Market size and forecast, by Technology Type
- 8.3.4. Market size and forecast, by Protein Type
- 8.3.5. Market size and forecast, by End User
- 8.3.6. Market size and forecast, by country
- 8.3.6.1. Germany
- 8.3.6.1.1. Market size and forecast, by Product
- 8.3.6.1.2. Market size and forecast, by Technology Type
- 8.3.6.1.3. Market size and forecast, by Protein Type
- 8.3.6.1.4. Market size and forecast, by End User
- 8.3.6.2. France
- 8.3.6.2.1. Market size and forecast, by Product
- 8.3.6.2.2. Market size and forecast, by Technology Type
- 8.3.6.2.3. Market size and forecast, by Protein Type
- 8.3.6.2.4. Market size and forecast, by End User
- 8.3.6.3. UK
- 8.3.6.3.1. Market size and forecast, by Product
- 8.3.6.3.2. Market size and forecast, by Technology Type
- 8.3.6.3.3. Market size and forecast, by Protein Type
- 8.3.6.3.4. Market size and forecast, by End User
- 8.3.6.4. Italy
- 8.3.6.4.1. Market size and forecast, by Product
- 8.3.6.4.2. Market size and forecast, by Technology Type
- 8.3.6.4.3. Market size and forecast, by Protein Type
- 8.3.6.4.4. Market size and forecast, by End User
- 8.3.6.5. Spain
- 8.3.6.5.1. Market size and forecast, by Product
- 8.3.6.5.2. Market size and forecast, by Technology Type
- 8.3.6.5.3. Market size and forecast, by Protein Type
- 8.3.6.5.4. Market size and forecast, by End User
- 8.3.6.6. Rest of Europe
- 8.3.6.6.1. Market size and forecast, by Product
- 8.3.6.6.2. Market size and forecast, by Technology Type
- 8.3.6.6.3. Market size and forecast, by Protein Type
- 8.3.6.6.4. Market size and forecast, by End User
- 8.4. Asia-Pacific
- 8.4.1. Key market trends, growth factors and opportunities
- 8.4.2. Market size and forecast, by Product
- 8.4.3. Market size and forecast, by Technology Type
- 8.4.4. Market size and forecast, by Protein Type
- 8.4.5. Market size and forecast, by End User
- 8.4.6. Market size and forecast, by country
- 8.4.6.1. Japan
- 8.4.6.1.1. Market size and forecast, by Product
- 8.4.6.1.2. Market size and forecast, by Technology Type
- 8.4.6.1.3. Market size and forecast, by Protein Type
- 8.4.6.1.4. Market size and forecast, by End User
- 8.4.6.2. China
- 8.4.6.2.1. Market size and forecast, by Product
- 8.4.6.2.2. Market size and forecast, by Technology Type
- 8.4.6.2.3. Market size and forecast, by Protein Type
- 8.4.6.2.4. Market size and forecast, by End User
- 8.4.6.3. India
- 8.4.6.3.1. Market size and forecast, by Product
- 8.4.6.3.2. Market size and forecast, by Technology Type
- 8.4.6.3.3. Market size and forecast, by Protein Type
- 8.4.6.3.4. Market size and forecast, by End User
- 8.4.6.4. Australia
- 8.4.6.4.1. Market size and forecast, by Product
- 8.4.6.4.2. Market size and forecast, by Technology Type
- 8.4.6.4.3. Market size and forecast, by Protein Type
- 8.4.6.4.4. Market size and forecast, by End User
- 8.4.6.5. South Korea
- 8.4.6.5.1. Market size and forecast, by Product
- 8.4.6.5.2. Market size and forecast, by Technology Type
- 8.4.6.5.3. Market size and forecast, by Protein Type
- 8.4.6.5.4. Market size and forecast, by End User
- 8.4.6.6. Rest of Asia-Pacific
- 8.4.6.6.1. Market size and forecast, by Product
- 8.4.6.6.2. Market size and forecast, by Technology Type
- 8.4.6.6.3. Market size and forecast, by Protein Type
- 8.4.6.6.4. Market size and forecast, by End User
- 8.5. LAMEA
- 8.5.1. Key market trends, growth factors and opportunities
- 8.5.2. Market size and forecast, by Product
- 8.5.3. Market size and forecast, by Technology Type
- 8.5.4. Market size and forecast, by Protein Type
- 8.5.5. Market size and forecast, by End User
- 8.5.6. Market size and forecast, by country
- 8.5.6.1. Brazil
- 8.5.6.1.1. Market size and forecast, by Product
- 8.5.6.1.2. Market size and forecast, by Technology Type
- 8.5.6.1.3. Market size and forecast, by Protein Type
- 8.5.6.1.4. Market size and forecast, by End User
- 8.5.6.2. Saudi Arabia
- 8.5.6.2.1. Market size and forecast, by Product
- 8.5.6.2.2. Market size and forecast, by Technology Type
- 8.5.6.2.3. Market size and forecast, by Protein Type
- 8.5.6.2.4. Market size and forecast, by End User
- 8.5.6.3. South Africa
- 8.5.6.3.1. Market size and forecast, by Product
- 8.5.6.3.2. Market size and forecast, by Technology Type
- 8.5.6.3.3. Market size and forecast, by Protein Type
- 8.5.6.3.4. Market size and forecast, by End User
- 8.5.6.4. Rest of LAMEA
- 8.5.6.4.1. Market size and forecast, by Product
- 8.5.6.4.2. Market size and forecast, by Technology Type
- 8.5.6.4.3. Market size and forecast, by Protein Type
- 8.5.6.4.4. Market size and forecast, by End User
- CHAPTER 9: COMPETITIVE LANDSCAPE
- 9.1. Introduction
- 9.2. Top winning strategies
- 9.3. Product mapping of top 10 player
- 9.4. Competitive dashboard
- 9.5. Competitive heatmap
- 9.6. Top player positioning, 2022
- CHAPTER 10: COMPANY PROFILES
- 10.1. Agilent Technologies, Inc.
- 10.1.1. Company overview
- 10.1.2. Key executives
- 10.1.3. Company snapshot
- 10.1.4. Operating business segments
- 10.1.5. Product portfolio
- 10.1.6. Business performance
- 10.2. Thermo Fisher Scientific Inc.
- 10.2.1. Company overview
- 10.2.2. Key executives
- 10.2.3. Company snapshot
- 10.2.4. Operating business segments
- 10.2.5. Product portfolio
- 10.2.6. Business performance
- 10.2.7. Key strategic moves and developments
- 10.3. Promega Corporation
- 10.3.1. Company overview
- 10.3.2. Key executives
- 10.3.3. Company snapshot
- 10.3.4. Operating business segments
- 10.3.5. Product portfolio
- 10.4. New England Biolabs, Inc.
- 10.4.1. Company overview
- 10.4.2. Key executives
- 10.4.3. Company snapshot
- 10.4.4. Operating business segments
- 10.4.5. Product portfolio
- 10.5. Danaher Corporation
- 10.5.1. Company overview
- 10.5.2. Key executives
- 10.5.3. Company snapshot
- 10.5.4. Operating business segments
- 10.5.5. Product portfolio
- 10.5.6. Business performance
- 10.5.7. Key strategic moves and developments
- 10.6. Creative Biolabs Limited
- 10.6.1. Company overview
- 10.6.2. Key executives
- 10.6.3. Company snapshot
- 10.6.4. Operating business segments
- 10.6.5. Product portfolio
- 10.7. Bio-Rad Laboratories, Inc.
- 10.7.1. Company overview
- 10.7.2. Key executives
- 10.7.3. Company snapshot
- 10.7.4. Operating business segments
- 10.7.5. Product portfolio
- 10.7.6. Business performance
- 10.8. Amgen, Inc.
- 10.8.1. Company overview
- 10.8.2. Key executives
- 10.8.3. Company snapshot
- 10.8.4. Operating business segments
- 10.8.5. Product portfolio
- 10.8.6. Business performance
- 10.8.7. Key strategic moves and developments
- 10.9. Jena Bioscience GmbH
- 10.9.1. Company overview
- 10.9.2. Key executives
- 10.9.3. Company snapshot
- 10.9.4. Operating business segments
- 10.9.5. Product portfolio
- 10.10. TAKARA HOLDINGS INC.
- 10.10.1. Company overview
- 10.10.2. Key executives
- 10.10.3. Company snapshot
- 10.10.4. Operating business segments
- 10.10.5. Product portfolio
- 10.10.6. Business performance
- LIST OF TABLES
- TABLE 01. GLOBAL PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 02. PROTEIN ENGINEERING MARKET FOR INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
- TABLE 03. PROTEIN ENGINEERING MARKET FOR CONSUMABLES, BY REGION, 2022-2032 ($MILLION)
- TABLE 04. PROTEIN ENGINEERING MARKET FOR SOFTWARE, BY REGION, 2022-2032 ($MILLION)
- TABLE 05. GLOBAL PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 06. PROTEIN ENGINEERING MARKET FOR RATIONAL OR SITE DIRECTED MUTAGENESIS, BY REGION, 2022-2032 ($MILLION)
- TABLE 07. PROTEIN ENGINEERING MARKET FOR IRRATIONAL OR RANDOM MUTAGENESIS, BY REGION, 2022-2032 ($MILLION)
- TABLE 08. GLOBAL PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 09. PROTEIN ENGINEERING MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 2022-2032 ($MILLION)
- TABLE 10. PROTEIN ENGINEERING MARKET FOR INSULIN, BY REGION, 2022-2032 ($MILLION)
- TABLE 11. PROTEIN ENGINEERING MARKET FOR ERYTHROPOIETIN, BY REGION, 2022-2032 ($MILLION)
- TABLE 12. PROTEIN ENGINEERING MARKET FOR INTERFERON, BY REGION, 2022-2032 ($MILLION)
- TABLE 13. PROTEIN ENGINEERING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
- TABLE 14. GLOBAL PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 15. PROTEIN ENGINEERING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)
- TABLE 16. PROTEIN ENGINEERING MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2022-2032 ($MILLION)
- TABLE 17. PROTEIN ENGINEERING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2022-2032 ($MILLION)
- TABLE 18. PROTEIN ENGINEERING MARKET, BY REGION, 2022-2032 ($MILLION)
- TABLE 19. NORTH AMERICA PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 20. NORTH AMERICA PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 21. NORTH AMERICA PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 22. NORTH AMERICA PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 23. NORTH AMERICA PROTEIN ENGINEERING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 24. U.S. PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 25. U.S. PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 26. U.S. PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 27. U.S. PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 28. CANADA PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 29. CANADA PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 30. CANADA PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 31. CANADA PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 32. MEXICO PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 33. MEXICO PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 34. MEXICO PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 35. MEXICO PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 36. EUROPE PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 37. EUROPE PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 38. EUROPE PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 39. EUROPE PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 40. EUROPE PROTEIN ENGINEERING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 41. GERMANY PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 42. GERMANY PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 43. GERMANY PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 44. GERMANY PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 45. FRANCE PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 46. FRANCE PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 47. FRANCE PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 48. FRANCE PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 49. UK PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 50. UK PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 51. UK PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 52. UK PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 53. ITALY PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 54. ITALY PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 55. ITALY PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 56. ITALY PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 57. SPAIN PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 58. SPAIN PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 59. SPAIN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 60. SPAIN PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 61. REST OF EUROPE PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 62. REST OF EUROPE PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 63. REST OF EUROPE PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 64. REST OF EUROPE PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 65. ASIA-PACIFIC PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 66. ASIA-PACIFIC PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 67. ASIA-PACIFIC PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 68. ASIA-PACIFIC PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 69. ASIA-PACIFIC PROTEIN ENGINEERING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 70. JAPAN PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 71. JAPAN PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 72. JAPAN PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 73. JAPAN PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 74. CHINA PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 75. CHINA PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 76. CHINA PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 77. CHINA PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 78. INDIA PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 79. INDIA PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 80. INDIA PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 81. INDIA PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 82. AUSTRALIA PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 83. AUSTRALIA PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 84. AUSTRALIA PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 85. AUSTRALIA PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 86. SOUTH KOREA PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 87. SOUTH KOREA PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 88. SOUTH KOREA PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 89. SOUTH KOREA PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 90. REST OF ASIA-PACIFIC PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 91. REST OF ASIA-PACIFIC PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 92. REST OF ASIA-PACIFIC PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 93. REST OF ASIA-PACIFIC PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 94. LAMEA PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 95. LAMEA PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 96. LAMEA PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 97. LAMEA PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 98. LAMEA PROTEIN ENGINEERING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 99. BRAZIL PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 100. BRAZIL PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 101. BRAZIL PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 102. BRAZIL PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 103. SAUDI ARABIA PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 104. SAUDI ARABIA PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 105. SAUDI ARABIA PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 106. SAUDI ARABIA PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 107. SOUTH AFRICA PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 108. SOUTH AFRICA PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 109. SOUTH AFRICA PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 110. SOUTH AFRICA PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 111. REST OF LAMEA PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
- TABLE 112. REST OF LAMEA PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022-2032 ($MILLION)
- TABLE 113. REST OF LAMEA PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022-2032 ($MILLION)
- TABLE 114. REST OF LAMEA PROTEIN ENGINEERING MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 115. AGILENT TECHNOLOGIES, INC.: KEY EXECUTIVES
- TABLE 116. AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
- TABLE 117. AGILENT TECHNOLOGIES, INC.: PRODUCT SEGMENTS
- TABLE 118. AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
- TABLE 119. THERMO FISHER SCIENTIFIC INC. : KEY EXECUTIVES
- TABLE 120. THERMO FISHER SCIENTIFIC INC. : COMPANY SNAPSHOT
- TABLE 121. THERMO FISHER SCIENTIFIC INC. : PRODUCT SEGMENTS
- TABLE 122. THERMO FISHER SCIENTIFIC INC. : SERVICE SEGMENTS
- TABLE 123. THERMO FISHER SCIENTIFIC INC. : PRODUCT PORTFOLIO
- TABLE 124. THERMO FISHER SCIENTIFIC INC. : KEY STRATERGIES
- TABLE 125. PROMEGA CORPORATION: KEY EXECUTIVES
- TABLE 126. PROMEGA CORPORATION: COMPANY SNAPSHOT
- TABLE 127. PROMEGA CORPORATION: PRODUCT SEGMENTS
- TABLE 128. PROMEGA CORPORATION: SERVICE SEGMENTS
- TABLE 129. PROMEGA CORPORATION: PRODUCT PORTFOLIO
- TABLE 130. NEW ENGLAND BIOLABS, INC.: KEY EXECUTIVES
- TABLE 131. NEW ENGLAND BIOLABS, INC.: COMPANY SNAPSHOT
- TABLE 132. NEW ENGLAND BIOLABS, INC.: SERVICE SEGMENTS
- TABLE 133. NEW ENGLAND BIOLABS, INC.: PRODUCT PORTFOLIO
- TABLE 134. DANAHER CORPORATION: KEY EXECUTIVES
- TABLE 135. DANAHER CORPORATION: COMPANY SNAPSHOT
- TABLE 136. DANAHER CORPORATION: PRODUCT SEGMENTS
- TABLE 137. DANAHER CORPORATION: PRODUCT PORTFOLIO
- TABLE 138. DANAHER CORPORATION: KEY STRATERGIES
- TABLE 139. CREATIVE BIOLABS LIMITED: KEY EXECUTIVES
- TABLE 140. CREATIVE BIOLABS LIMITED: COMPANY SNAPSHOT
- TABLE 141. CREATIVE BIOLABS LIMITED: SERVICE SEGMENTS
- TABLE 142. CREATIVE BIOLABS LIMITED: PRODUCT PORTFOLIO
- TABLE 143. BIO-RAD LABORATORIES, INC. : KEY EXECUTIVES
- TABLE 144. BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
- TABLE 145. BIO-RAD LABORATORIES, INC. : PRODUCT SEGMENTS
- TABLE 146. BIO-RAD LABORATORIES, INC. : PRODUCT PORTFOLIO
- TABLE 147. AMGEN, INC.: KEY EXECUTIVES
- TABLE 148. AMGEN, INC.: COMPANY SNAPSHOT
- TABLE 149. AMGEN, INC.: PRODUCT SEGMENTS
- TABLE 150. AMGEN, INC.: PRODUCT PORTFOLIO
- TABLE 151. AMGEN, INC.: KEY STRATERGIES
- TABLE 152. JENA BIOSCIENCE GMBH: KEY EXECUTIVES
- TABLE 153. JENA BIOSCIENCE GMBH: COMPANY SNAPSHOT
- TABLE 154. JENA BIOSCIENCE GMBH: PRODUCT SEGMENTS
- TABLE 155. JENA BIOSCIENCE GMBH: PRODUCT PORTFOLIO
- TABLE 156. TAKARA HOLDINGS INC.: KEY EXECUTIVES
- TABLE 157. TAKARA HOLDINGS INC.: COMPANY SNAPSHOT
- TABLE 158. TAKARA HOLDINGS INC.: PRODUCT SEGMENTS
- TABLE 159. TAKARA HOLDINGS INC.: PRODUCT PORTFOLIO
- LIST OF FIGURES
- FIGURE 01. PROTEIN ENGINEERING MARKET, 2022-2032
- FIGURE 02. SEGMENTATION OF PROTEIN ENGINEERING MARKET,2022-2032
- FIGURE 03. TOP IMPACTING FACTORS IN PROTEIN ENGINEERING MARKET (2022 TO 2032)
- FIGURE 04. TOP INVESTMENT POCKETS IN PROTEIN ENGINEERING MARKET (2023-2032)
- FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 07. MODERATE THREAT OF SUBSTITUTES
- FIGURE 08. HIGH INTENSITY OF RIVALRY
- FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 10. GLOBAL PROTEIN ENGINEERING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 11. PROTEIN ENGINEERING MARKET, BY PRODUCT, 2022 AND 2032(%)
- FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PROTEIN ENGINEERING MARKET FOR INSTRUMENTS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 13. COMPARATIVE SHARE ANALYSIS OF PROTEIN ENGINEERING MARKET FOR CONSUMABLES, BY COUNTRY 2022 AND 2032(%)
- FIGURE 14. COMPARATIVE SHARE ANALYSIS OF PROTEIN ENGINEERING MARKET FOR SOFTWARE, BY COUNTRY 2022 AND 2032(%)
- FIGURE 15. PROTEIN ENGINEERING MARKET, BY TECHNOLOGY TYPE, 2022 AND 2032(%)
- FIGURE 16. COMPARATIVE SHARE ANALYSIS OF PROTEIN ENGINEERING MARKET FOR RATIONAL OR SITE DIRECTED MUTAGENESIS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 17. COMPARATIVE SHARE ANALYSIS OF PROTEIN ENGINEERING MARKET FOR IRRATIONAL OR RANDOM MUTAGENESIS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 18. PROTEIN ENGINEERING MARKET, BY PROTEIN TYPE, 2022 AND 2032(%)
- FIGURE 19. COMPARATIVE SHARE ANALYSIS OF PROTEIN ENGINEERING MARKET FOR MONOCLONAL ANTIBODIES, BY COUNTRY 2022 AND 2032(%)
- FIGURE 20. COMPARATIVE SHARE ANALYSIS OF PROTEIN ENGINEERING MARKET FOR INSULIN, BY COUNTRY 2022 AND 2032(%)
- FIGURE 21. COMPARATIVE SHARE ANALYSIS OF PROTEIN ENGINEERING MARKET FOR ERYTHROPOIETIN, BY COUNTRY 2022 AND 2032(%)
- FIGURE 22. COMPARATIVE SHARE ANALYSIS OF PROTEIN ENGINEERING MARKET FOR INTERFERON, BY COUNTRY 2022 AND 2032(%)
- FIGURE 23. COMPARATIVE SHARE ANALYSIS OF PROTEIN ENGINEERING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 24. PROTEIN ENGINEERING MARKET, BY END USER, 2022 AND 2032(%)
- FIGURE 25. COMPARATIVE SHARE ANALYSIS OF PROTEIN ENGINEERING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY 2022 AND 2032(%)
- FIGURE 26. COMPARATIVE SHARE ANALYSIS OF PROTEIN ENGINEERING MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY 2022 AND 2032(%)
- FIGURE 27. COMPARATIVE SHARE ANALYSIS OF PROTEIN ENGINEERING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 28. PROTEIN ENGINEERING MARKET BY REGION, 2022 AND 2032(%)
- FIGURE 29. U.S. PROTEIN ENGINEERING MARKET, 2022-2032 ($MILLION)
- FIGURE 30. CANADA PROTEIN ENGINEERING MARKET, 2022-2032 ($MILLION)
- FIGURE 31. MEXICO PROTEIN ENGINEERING MARKET, 2022-2032 ($MILLION)
- FIGURE 32. GERMANY PROTEIN ENGINEERING MARKET, 2022-2032 ($MILLION)
- FIGURE 33. FRANCE PROTEIN ENGINEERING MARKET, 2022-2032 ($MILLION)
- FIGURE 34. UK PROTEIN ENGINEERING MARKET, 2022-2032 ($MILLION)
- FIGURE 35. ITALY PROTEIN ENGINEERING MARKET, 2022-2032 ($MILLION)
- FIGURE 36. SPAIN PROTEIN ENGINEERING MARKET, 2022-2032 ($MILLION)
- FIGURE 37. REST OF EUROPE PROTEIN ENGINEERING MARKET, 2022-2032 ($MILLION)
- FIGURE 38. JAPAN PROTEIN ENGINEERING MARKET, 2022-2032 ($MILLION)
- FIGURE 39. CHINA PROTEIN ENGINEERING MARKET, 2022-2032 ($MILLION)
- FIGURE 40. INDIA PROTEIN ENGINEERING MARKET, 2022-2032 ($MILLION)
- FIGURE 41. AUSTRALIA PROTEIN ENGINEERING MARKET, 2022-2032 ($MILLION)
- FIGURE 42. SOUTH KOREA PROTEIN ENGINEERING MARKET, 2022-2032 ($MILLION)
- FIGURE 43. REST OF ASIA-PACIFIC PROTEIN ENGINEERING MARKET, 2022-2032 ($MILLION)
- FIGURE 44. BRAZIL PROTEIN ENGINEERING MARKET, 2022-2032 ($MILLION)
- FIGURE 45. SAUDI ARABIA PROTEIN ENGINEERING MARKET, 2022-2032 ($MILLION)
- FIGURE 46. SOUTH AFRICA PROTEIN ENGINEERING MARKET, 2022-2032 ($MILLION)
- FIGURE 47. REST OF LAMEA PROTEIN ENGINEERING MARKET, 2022-2032 ($MILLION)
- FIGURE 48. TOP WINNING STRATEGIES, BY YEAR (2021-2023)
- FIGURE 49. TOP WINNING STRATEGIES, BY DEVELOPMENT (2021-2023)
- FIGURE 50. TOP WINNING STRATEGIES, BY COMPANY (2021-2023)
- FIGURE 51. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 52. COMPETITIVE DASHBOARD
- FIGURE 53. COMPETITIVE HEATMAP: PROTEIN ENGINEERING MARKET
- FIGURE 54. TOP PLAYER POSITIONING, 2022
- FIGURE 55. AGILENT TECHNOLOGIES, INC.: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 56. AGILENT TECHNOLOGIES, INC.: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
- FIGURE 57. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 58. AGILENT TECHNOLOGIES, INC.: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 59. THERMO FISHER SCIENTIFIC INC. : NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 60. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 61. THERMO FISHER SCIENTIFIC INC. : REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 62. DANAHER CORPORATION: NET SALES, 2020-2022 ($MILLION)
- FIGURE 63. DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 64. DANAHER CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 65. BIO-RAD LABORATORIES, INC. : NET SALES, 2020-2022 ($MILLION)
- FIGURE 66. BIO-RAD LABORATORIES, INC.
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook